Winchester, MA, United States of America

Manohar G Kalyanpur

This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manohar G Kalyanpur. Retrieved from https://idiyas.com/inventor/manohar-g-kalyanpur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manohar G Kalyanpur: Innovator in Antibiotic Development

Introduction

Manohar G Kalyanpur is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of antibiotics, particularly through his work with a new variety of Micromonospora carbonacea. His innovative approach has led to the development of a unique antibiotic complex.

Latest Patents

Kalyanpur holds a patent for the "Antibiotic 13-384 complex from Micromonospora carbonacea var africana." This antibiotic complex is derived from the newly identified strain, Micromonospora carbonacea var africana NRRL 15099. His work in this area showcases his commitment to advancing medical science and improving health outcomes.

Career Highlights

Throughout his career, Kalyanpur has been associated with Schering Corporation, where he has contributed to various research initiatives. His expertise in microbiology and antibiotic development has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Kalyanpur has collaborated with esteemed colleagues such as Jay A Waitz and Mahesh G Patel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Manohar G Kalyanpur's work in antibiotic development exemplifies the impact of innovative research in healthcare. His contributions continue to influence the field and pave the way for future advancements in antibiotic therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…